Oxon Epidemiology Limited
06489173
Some Concerns
- Current liabilities exceed current assets (-10)
- 1 outstanding charge (-2)
Details
Compliance
Accounts
Confirmation statement
Industry
Officers
director · Since 30/01/2008
BOOK KEEPER
BRITISH · ENGLAND · Age 64
Also on 2 other boards
Persons with Significant Control
Mr Nawab Qizilbash
British · England · Age 70
200 Northcote Road, E17 7DH
Notified 06/04/2016
Former PSCs
Ms Shahnaz Tasneem Qizilbash
Ceased 13/07/2018
Charges1 outstanding
DCD TRUSTEES LIMITED, THE TRUSTEES OF THE OXON EPIDEMIOLOGY PENSION SCHEME BEING (AT THE DATE H
THE TRUSTEES OF OXON EPIDEMIOLOGY PENSION SCHEME BEING NAWAB QIZILBASH OF AVENIDA ALFONSO XIII
CompanyRankvs 25+ SIC 86220 peers80
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Risk deductions
Outstanding charges: -10 pts
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/01/2025
Net Worth
£1.5M
Balance sheet strength
Cash
£393k
Cash in the bank
Net Current Assets
£2.3M
Working capital
Current Assets
£2.9M
Current Liabilities
£551k
Fixed Assets
£46k
Debtors
£2.5M
Tax at Year End(2024)
Director Loans(2024)
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit | Est. Revenue |
|---|---|---|---|
| 2025 | 5.18 | -£99k | — |
| 2024 | 6.26 | -£39k | £3.6M |
| 2023 | 6.82 | +£448k | £668k |
| 2022 | 4.00 | +£418k | £1.1M |
| 2021 | 2.70 | +£466k | £632k |
| 2020 | 1.69 | +£402k | — |
| 2019 | 1.81 | — | — |
Derived from filed accounts. Not audited figures.